Design and validation of a histologic scoring system for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).

被引：0

作者：

Kleiner, DE

Brunt, EM

Van Natta, ML

Behling, C

Contos, MJ

Cummings, OW

Ferrell, LD

Liu, YC

Torbenson, MS

Yeh, M

McCullough, AJ

Sanyal, AJ

机构：

[1] St Louis Univ, St Louis, MO 63103 USA

[2] Johns Hopkins Univ, Baltimore, MD 21218 USA

[3] Univ Calif San Diego, San Diego, CA 92103 USA

[4] Virginia Commonwealth Univ, Richmond, VA USA

[5] Indiana Univ, Indianapolis, IN 46204 USA

[6] Univ Calif San Francisco, San Francisco, CA 94143 USA

[7] Metrohlth Med Ctr, Cleveland, OH USA

[8] Univ Washington, Med Ctr, Seattle, WA 98195 USA

来源：

HEPATOLOGY | 2003年 / 38卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

160

引用

页码：233A / 233A

页数：1

共 50 条

[1] Non-alcoholic fatty liver disease (NAFLD). Non-alcoholic steatohepatitis - NASH
Keller, KM
MONATSSCHRIFT KINDERHEILKUNDE, 2004, 152 (08) : 864 - 869
[2] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment
Bugianesi, E
Marzocchi, R
Villanova, N
Marchesini, G
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1105 - 1116
[3] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
Jürgen Kurt Rockstroh
Current HIV/AIDS Reports, 2017, 14 : 47 - 53
[4] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
Rockstroh, Juergen Kurt
CURRENT HIV/AIDS REPORTS, 2017, 14 (02) : 47 - 53
[5] Non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) - A growing epidemic
South, K
GASTROENTEROLOGY NURSING, 2006, 29 (02) : 169 - 169
[6] Non-alcoholic Fatty Liver Disease (NAFLD) and non-alcoholic Steatohepatitis (NASH): Pathophysiology and Nutritional Aspects
Schattenberg, Joern M.
ERNAHRUNGS UMSCHAU, 2015, 62 (02): : M92 - M100
[7] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course
Cortez-Pinto, H
Camilo, ME
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1089 - 1104
[8] Linagliptin is an Effective Therapeutic for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH)
Klein, Thomas
Mark, Michael
DIABETES, 2012, 61 : A265 - A266
[9] Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
Miele, Luca
Forgione, Alessandra
Gasbarrini, Giovanni
Grieco, Antonio
TRANSLATIONAL RESEARCH, 2007, 149 (03) : 114 - 125
[10] Recurrence of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Following Liver Transplantation for NASH Cirrhosis
Matsuoka, Lea
Slaughter, James
Campbell, Kathyrn
Kerr, Ashlie
Hamel, Stephanie
Garza, Carissa
Chotai, Pranit
Alexopoulos, Sophoclis
Scanga, Andrew
AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 15 - 15

← 1 2 3 4 5 →